Nuclera

Nuclera is a biotechnology company based in the UK and the US, founded in 2013 by PhD graduates from the University of Cambridge. Headquartered in Cambridge, UK, with a second location in Boston, Massachusetts, Nuclera aims to enhance human health by providing rapid protein prototyping technology for life science researchers. Their innovative approach addresses challenges in drug discovery by enabling protein production in under 48 hours. The company's flagship product, eProtein Discovery™, is a benchtop multiplex protein screening system that combines cell-free protein synthesis, eDNA™ synthesis, and digital microfluidics. This system allows researchers to automate the screening and optimization of protein constructs, significantly speeding up drug discovery processes. Nuclera has established partnerships with leading academic institutions, including the University of Cambridge and MIT, and has produced over 1,000 proteins to date. With a strong focus on scalable protein access, Nuclera supports various applications in healthcare, pharma, and research.